Form 4: Pediatrix Medical Group Director Sells 27,600 Shares

A director of Pediatrix Medical Group, Mark S. Ordan, sold 27,600 shares of common stock at a weighted average price of $15.35.

Summary

• Mark S. Ordan, a director at Pediatrix Medical Group, sold 27,600 shares of the company's common stock on November 13, 2024.
• The shares were sold at a weighted average price of $15.35 per share.
• The sale was executed in multiple transactions with prices ranging from $15.17 to $15.52.
• Following the transaction, Mr. Ordan directly owns 138,683 shares of Pediatrix Medical Group common stock.

Sentiment

Score: 5

Explanation: This is a neutral event, a routine disclosure of a director's stock sale. It doesn't indicate positive or negative sentiment about the company's performance.

Industry Context

This is a routine disclosure of a stock sale by a company director, which is a common occurrence in the corporate world. It does not indicate any specific trend in the healthcare industry.

Comparison to Industry Standards

• Sales of shares by directors are a normal part of corporate activity and are regularly disclosed via Form 4 filings.
• The volume of shares sold is not unusual for a director's transaction.
• The price range of the sale is within a normal trading range for the stock.

Stakeholder Impact

• The sale of shares by a director may have a minor impact on shareholder sentiment, but is unlikely to have a significant impact on the company's operations or other stakeholders.

Key Dates

Keywords

Pediatrix Medical Group, director, stock sale, insider trading, common stock, Mark S. Ordan